Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pirie

Showing results (111-120 of 117) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 117 results.
Plos Medicine|May 15, 2019
Predicting seizures in pregnant women with epilepsy: Development and external validation of a prognostic modelJohn Allotey, Borja M Fernandez-Felix, Javier Zamora, et al.
BMC Pregnancy and Childbirth|December 30, 2017
Blood pressure self-monitoring in pregnancy: examining feasibility in a prospective cohort studyKatherine L Tucker, Kathryn S Taylor, Carole Crawford, et al.
Endocrine|April 27, 2001
Preclinical pharmacology of CP-424,391, an orally active pyrazolinone-piperidine [correction of pyrazolidinone-piperidine] growth hormone secretagogueL C Pan, P A Carpino, B A Lefker, et al.
Endocrinology|April 7, 1998
Effects of CP-336,156, a new, nonsteroidal estrogen agonist/antagonist, on bone, serum cholesterol, uterus and body composition in rat modelsH Z Ke, V M Paralkar, W A Grasser, et al.
Journal of Medicinal Chemistry|July 31, 1998
Discovery and preclinical pharmacology of a novel, potent, nonsteroidal estrogen receptor agonist/antagonist, CP-336156, a diaryltetrahydronaphthaleneR L Rosati, P Da Silva Jardine, K O Cameron, et al.
Bioorganic & Medicinal Chemistry|January 23, 2003
Pyrazolinone-piperidine dipeptide growth hormone secretagogues (GHSs). Discovery of capromorelinPhilip A Carpino, Bruce A Lefker, Steven M Toler, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2002
Discovery and biological characterization of capromorelin analogues with extended half-livesPhilip A Carpino, Bruce A Lefker, Steven M Toler, et al.
Pageof 12

Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
Plos Medicine|May 15, 2019
Predicting seizures in pregnant women with epilepsy: Development and external validation of a prognostic modelJohn Allotey, Borja M Fernandez-Felix, Javier Zamora, et al.
BMC Pregnancy and Childbirth|December 30, 2017
Blood pressure self-monitoring in pregnancy: examining feasibility in a prospective cohort studyKatherine L Tucker, Kathryn S Taylor, Carole Crawford, et al.
Endocrine|April 27, 2001
Preclinical pharmacology of CP-424,391, an orally active pyrazolinone-piperidine [correction of pyrazolidinone-piperidine] growth hormone secretagogueL C Pan, P A Carpino, B A Lefker, et al.
Endocrinology|April 7, 1998
Effects of CP-336,156, a new, nonsteroidal estrogen agonist/antagonist, on bone, serum cholesterol, uterus and body composition in rat modelsH Z Ke, V M Paralkar, W A Grasser, et al.
Journal of Medicinal Chemistry|July 31, 1998
Discovery and preclinical pharmacology of a novel, potent, nonsteroidal estrogen receptor agonist/antagonist, CP-336156, a diaryltetrahydronaphthaleneR L Rosati, P Da Silva Jardine, K O Cameron, et al.
Bioorganic & Medicinal Chemistry|January 23, 2003
Pyrazolinone-piperidine dipeptide growth hormone secretagogues (GHSs). Discovery of capromorelinPhilip A Carpino, Bruce A Lefker, Steven M Toler, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2002
Discovery and biological characterization of capromorelin analogues with extended half-livesPhilip A Carpino, Bruce A Lefker, Steven M Toler, et al.
Pageof 12